Pharmacokinetics and renal function in preterm infants

被引:61
|
作者
vandenAnker, JN [1 ]
机构
[1] ERASMUS UNIV ROTTERDAM, DEPT PEDIAT, ROTTERDAM, NETHERLANDS
关键词
clinical pharmacokinetics; development pharmacology; glomerular filtration rate; neonatal pharmacology; preterm infants; renal function;
D O I
10.1111/j.1651-2227.1996.tb13942.x
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
There is an increase in the survival rate of preterm infants due to rapid advances in medical knowledge and technology. However, the research and attention paid to the proper use of pharmacotherapy in these infants is still a relatively underdeveloped field. Effective and safe drug therapy requires a thorough understanding of human developmental biology and of the dynamic ontogeny of drug absorption, drug disposition? drug metabolism, and drug excretion. It is apparent that maturation of organ system function and changes in body composition during gestation and during the neonatal period exert a significant effect on the disposition of drugs. This review focuses on the effects of maturational and drug-induced changes in renal function on clinical pharmacokinetics in the preterm infant.
引用
收藏
页码:1393 / 1399
页数:7
相关论文
共 50 条
  • [21] Renal function and kidney length in preterm infants with nephrocalcinosis: a longitudinal study
    Vasileios Giapros
    Constantina Tsoni
    Anna Challa
    Vasileios Cholevas
    Maria Argyropoulou
    Frederica Papadopoulou
    Ekaterini Siomou
    Aikaterini Drougia
    Styliani Andronikou
    Pediatric Nephrology, 2011, 26 : 1873 - 1880
  • [22] EARLY POSTNATAL IMPAIRMENT OF RENAL FUNCTION IN INDIGENOUS INFANTS BORN PRETERM
    Sutherland, M. R.
    Ryan, D.
    Davison, B.
    Chatfield, M.
    Diwakarla, S.
    Hoy, W. E.
    Singh, G.
    Black, M. J.
    NEPHROLOGY, 2017, 22 : 31 - 31
  • [23] Nephrotoxic drugs and renal function in preterm infants: are urinary biomarkers the answer?
    Stephen J. McWilliam
    Mark A. Turner
    Jonathan M. Davis
    Pediatric Research, 2022, 92 : 22 - 24
  • [24] Nephrotoxic drugs and renal function in preterm infants: are urinary biomarkers the answer?
    McWilliam, Stephen J.
    Turner, Mark A.
    Davis, Jonathan M.
    PEDIATRIC RESEARCH, 2022, 92 (01) : 22 - 24
  • [25] RENAL CALCIFICATIONS IN PRETERM INFANTS
    ITAMI, N
    KAWAGUTI, M
    AKUTSU, Y
    MIZUTANI, K
    TOCHIMARU, H
    TAKEKOSHI, Y
    JOURNAL OF PEDIATRICS, 1989, 114 (06): : 1068 - 1068
  • [26] Pharmacokinetics and metabolism of oral midazolam in preterm infants
    de Wildt, SN
    Kearns, GL
    Hop, WCJ
    Murry, DJ
    Abdel-Rahman, SM
    van den Anker, JN
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 53 (04) : 390 - 392
  • [27] PHARMACOKINETICS OF HUMAN RECOMBINANT ERYTHROPOIETIN IN PRETERM INFANTS
    BROWN, MS
    JONES, MA
    OHLS, RK
    CHRISTENSEN, RD
    CLINICAL RESEARCH, 1993, 41 (01): : A22 - A22
  • [28] Population pharmacokinetics of fentanyl in very preterm infants
    Bardol, Maddlie
    Fellman, Vineta
    Norman, Elisabeth
    Standing, Joseph
    PEDIATRIC RESEARCH, 2021, 90 (SUPPL 1) : 35 - 36
  • [29] Population Pharmacokinetics of Nirsevimab in Preterm and Term Infants
    Clegg, Lindsay
    Freshwater, Ed
    Leach, Amanda
    Villafana, Tonya
    Hamren, Ulrika Waehlby
    JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 64 (05): : 555 - 567
  • [30] PHARMACOKINETICS OF ORAL AND INTRAVENOUS INDOMETHACIN IN PRETERM INFANTS
    BHAT, R
    VIDYASAGAR, D
    FISHER, E
    HASTREITER, A
    RAMIREZ, JL
    BURNS, L
    EVANS, M
    DEVELOPMENTAL PHARMACOLOGY AND THERAPEUTICS, 1980, 1 (2-3): : 101 - 110